These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21886452)

  • 61. Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review).
    Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
    Curr Genomics; 2009 Apr; 10(2):127-32. PubMed ID: 19794885
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Gender-specific aspects of Lynch syndrome--an update].
    Schneider R; Fürst A; Möslein G
    Z Gastroenterol; 2015 Aug; 53(8):789-93. PubMed ID: 26284327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
    Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
    Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
    Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endometrial cells of the "lower uterine segment" (LUS) in cervical smears obtained by endocervical brushings: a source of potential diagnostic pitfall.
    de Peralta-Venturino MN; Purslow MJ; Kini SR
    Diagn Cytopathol; 1995 May; 12(3):263-8; discussion 268-71. PubMed ID: 7621724
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes.
    Brown AK; Madom L; Moore R; Granai CO; DiSilvestro P
    Gynecol Oncol; 2007 Apr; 105(1):55-8. PubMed ID: 17157904
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidental screening of descending colon carcinoma by 18F-FDG PET/MR imaging in a patient with endometrial carcinoma: A case report of Lynch syndrome.
    Li X; Zhang X; Cui B; Ma J; Wang S; Lu J
    Front Oncol; 2022; 12():1115056. PubMed ID: 36761424
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microsatellite instability analysis in uterine cavity washings as a screening tool for endometrial cancer in Lynch syndrome.
    Bouquier J; Blons H; Narjoz C; Lécuru F; Laurent-Puig P; Bats AS
    Fam Cancer; 2011 Dec; 10(4):655-7. PubMed ID: 21822721
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review].
    Si JW; Wang L; Ba XJ; Zhang X; Dong Y; Zhang JX; Li WT; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):858-64. PubMed ID: 26474631
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
    Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
    Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
    Stoffel EM
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in Lynch syndrome.
    Bogani G; Ricci MT; Vitellaro M; Ditto A; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2019 May; 29(4):705-710. PubMed ID: 30772826
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recent advances in Lynch syndrome.
    Li X; Liu G; Wu W
    Exp Hematol Oncol; 2021 Jun; 10(1):37. PubMed ID: 34118983
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel germline mutation in hMLH1 in three Korean women with endometrial cancer in a family of Lynch syndrome: case report and literature review.
    Jung YJ; Kim HR; Kim MK; Lee EJ
    Hered Cancer Clin Pract; 2021 Jun; 19(1):28. PubMed ID: 34082788
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetics of endometrial cancers.
    Okuda T; Sekizawa A; Purwosunu Y; Nagatsuka M; Morioka M; Hayashi M; Okai T
    Obstet Gynecol Int; 2010; 2010():984013. PubMed ID: 20396392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.
    Dashti SG; Chau R; Ouakrim DA; Buchanan DD; Clendenning M; Young JP; Winship IM; Arnold J; Ahnen DJ; Haile RW; Casey G; Gallinger S; Thibodeau SN; Lindor NM; Le Marchand L; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    JAMA; 2015 Jul; 314(1):61-71. PubMed ID: 26151267
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients.
    Baudhuin LM; Ferber MJ; Winters JL; Steenblock KJ; Swanson RL; French AJ; Butz ML; Thibodeau SN
    Gastroenterology; 2005 Sep; 129(3):846-54. PubMed ID: 16143124
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report.
    Batman S; Rauh-Hain JA; Grinsfelder MO; Harrison R; Avila M; Cun H; How JA; Tandon N; Wang X; Hinchcliff E; Jazaeri AA; Schmeler KM
    Case Rep Oncol; 2023; 16(1):273-278. PubMed ID: 37123608
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors.
    Kogan L; Octeau D; Amajoud Z; Abitbol J; Laskov I; Ferenczy A; Pelmus M; Eisenberg N; Kessous R; Lau S; Yasmeen A; Gotlieb WH; Salvador S
    Gynecol Oncol Rep; 2018 May; 24():43-47. PubMed ID: 29915797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.